Effect of On-Demand Oral Pre-exposure Prophylaxis With Tenofovir/Emtricitabine on Herpes Simplex Virus-1/2 Incidence Among Men Who Have Sex With Men: A Substudy of the ANRS IPERGAY Trial
Author(s) -
MarieLaure Chaix,
Isabelle Charreau,
Claire Pintado,
Constance Delaugerre,
Nadia Mahjoub,
Laurent Cotte,
Catherine Capitant,
F. Raffi,
Éric Cua,
Gilles Pialoux,
Cécile Tremblay,
Laurence Meyer,
JeanMichel Molina,
Bénédicte Loze,
P Charbonneau,
Caroline Gatey,
Diane Ponscarme,
Pauline Penot,
Laurence Niedbalski,
R. Verón,
Juan F. Delgado,
Ernest Dallé,
S Parlier,
Isabelle Madelaine,
Julien Fonsart,
Marie Danet,
N Mezreb,
Khafil Moudachirou,
Stéphane Morel,
G Conort,
F Lorho,
M Meunier,
Willy Rozenbaum,
Julie Chas,
Christine Monfort,
J Foucoin,
B Boissavy,
S Cousseau,
S Huon,
A Djessima,
V Berrebi,
Anne Adda,
S. Le Nagat,
L. Zarka,
J Berdougo,
Christian Chidiac,
N. Mzoughi,
Fiona Clement,
A Decouty,
C Chapolard,
Matthieu Godinot,
C. Adouard-groslafeige,
J. Koffi,
Aymeric Pansu,
Ann De Becker,
Sophie Pailhes,
Fabrice Bonnet,
François Jeanblanc,
Céline BrochierArmanet,
X Teruin,
Soumaya El Rouby,
L Gilly,
C Etienne,
F Tolonin,
S Bréaud,
V Péchenot,
S Bagge,
T Cepitelli,
P. Roger,
E Rosenthal,
Antoine Chéret,
Pauline Cornavin,
Sarah Vandamme,
J Lambec,
N Dumon,
O Leclanche,
T. Huleux,
Raphaël Biekre,
Olivier Robineau,
Hugues Melliez,
H. Bazus,
A. Pasquet,
C Bernaud,
Michel Besnier,
B. Bonnet,
Nolwenn Hall,
M Cavellec,
H Hüe,
L Larmet,
Marina Vera Colás,
Rémy Choquet,
Catherine Beauvais,
Pascale Arlotto,
Claude Fortin,
Annie Talbot,
Annie Chamberland,
Andrew McKenzie,
Michael Blanchette,
Rodney Rousseau,
K Montheuth,
Joanne Otis,
David R. Thompson,
Michel Morin,
Mark A. Wainberg,
B Guillon,
Emmanuelle Netzer,
Nicolas Leturque,
J Binesse,
Valérie Foubert,
Marine Saouzanet,
F. Euphrasie,
Diane Carette,
J.-P. Aboulker,
Bruno Spire,
Luis SagaonTeyssier,
Marie Suzan,
Lisa Fressard,
Baptiste Demoulin,
G Cattin,
Nicolas Lorente,
Vincent Doré,
Lucie Marchand,
Soizic Le Mestre,
Anaïs Mennecier,
Elias Choucair,
Nicolas Etien,
Alpha Diallo,
Séverine Gibowski,
MarieChristine Simon,
Delfraissy Jf,
J M Le Gall,
A Djessima Taba,
B Dos Santos,
Vincent Coquelin,
Phillippe Brunet,
R Porion,
Daniela Rojas Castro,
Benoît Trottier,
JeanGuy Baril,
Nathalie Bajos,
Julie Timsit,
Gilles Peytavin,
Isabelle DurandZaleski,
J Aboulker,
Marie SuzanMonti,
Gabriel Girard,
Marie Préau,
Véronique Doré,
France Lert,
Cécile Rabian
Publication year - 2018
Publication title -
open forum infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.546
H-Index - 35
ISSN - 2328-8957
DOI - 10.1093/ofid/ofy295
Subject(s) - medicine , emtricitabine , pre exposure prophylaxis , incidence (geometry) , placebo , herpes simplex virus , men who have sex with men , population , tenofovir , virology , viral load , human immunodeficiency virus (hiv) , virus , antiretroviral therapy , environmental health , syphilis , physics , alternative medicine , pathology , optics
We evaluated the impact of on-demand oral tenofovir disoproxil fumarate (TDF)/emtricitabine (FTC) for pre-exposure prophylaxis (PrEP) on herpes simplex virus (HSV)-1/2 incidence among men who have sex with men (MSM) enrolled in the ANRS IPERGAY trial. Serum samples were tested at baseline and at the last visit for HSV-1/2 antibodies. Overall HSV-1 incidence was 11.7 per 100 person-years; 16.2 and 7.8 per 100 person-years in the TDF/FTC and placebo arm, respectively (P = .19). Overall HSV-2 incidence was 7.6 per 100 person-years; 8.1 and 7.0 per 100 person-years in the TDF/FTC and placebo arm, respectively (P = .75). On-demand oral PrEP with TDF/FTC failed to reduce HSV-1/2 incidence in this population.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom